Division of Gastroenterology, Hospital L.Curto, Polla, Sant'Arsenio, Italy.
Am J Gastroenterol. 2010 Jun;105(6):1284-91. doi: 10.1038/ajg.2009.687. Epub 2010 Jan 5.
We sought (i) to validate a new prediction rule of mortality (Progetto Nazionale Emorragia Digestiva (PNED) score) on an independent population with non-variceal upper gastrointestinal bleeding (UGIB) and (ii) to compare the accuracy of the Italian PNED score vs. the Rockall score in predicting the risk of death.
We conducted prospective validation of analysis of consecutive patients with UGIB at 21 hospitals from 2007 to 2008. Outcome measure was 30-day mortality. All the variables used to calculate the Rockall score as well as those identified in the Italian predictive model were considered. Calibration of the model was tested using the chi2 goodness-of-fit and performance characteristics with receiver operating characteristic (ROC) analysis. The area under the ROC curve (AUC) was used to quantify the diagnostic accuracy of the two predictive models.
Over a 16-month period, data on 1,360 patients were entered in a national database and analyzed. Peptic ulcer bleeding was recorded in 60.7% of cases. One or more comorbidities were present in 66% of patients. Endoscopic treatment was delivered in all high-risk patients followed by high-dose intravenous proton pump inhibitor in 95% of them. Sixty-six patients died (mortality 4.85%; 3.54-5.75). The PNED score showed a high discriminant capability and was significantly superior to the Rockall score in predicting the risk of death (AUC 0.81 (0.72-0.90) vs. 0.66 (0.60-0.72), P<0.000). Positive likelihood ratio for mortality in patients with a PNED risk score >8 was 16.05.
The Italian 10-point score for the prediction of death was successfully validated in this independent population of patients with non-variceal gastrointestinal bleeding. The PNED score is accurate and superior to the Rockall score. Further external validation at the international level is needed.
我们旨在(i)在非静脉曲张性上消化道出血(UGIB)的独立人群中验证新的死亡率预测规则(意大利出血性消化疾病研究项目(PNED)评分),(ii)比较意大利 PNED 评分与 Rockall 评分预测死亡风险的准确性。
我们对 2007 年至 2008 年 21 家医院连续收治的 UGIB 患者进行了前瞻性验证分析。结局测量为 30 天死亡率。所有用于计算 Rockall 评分的变量以及在意大利预测模型中确定的变量均被考虑在内。通过卡方拟合优度检验和接收者操作特征(ROC)分析来测试模型的校准。ROC 曲线下面积(AUC)用于量化两种预测模型的诊断准确性。
在 16 个月的时间内,全国数据库中录入并分析了 1360 例患者的数据。消化性溃疡出血占 60.7%。66%的患者存在一种或多种合并症。所有高危患者均接受内镜治疗,其中 95%的患者随后接受高剂量静脉质子泵抑制剂治疗。66 例患者死亡(死亡率 4.85%;3.54-5.75)。PNED 评分具有较高的鉴别能力,在预测死亡风险方面明显优于 Rockall 评分(AUC 0.81(0.72-0.90)vs. 0.66(0.60-0.72),P<0.000)。PNED 风险评分>8 分的患者死亡的阳性似然比为 16.05。
意大利的 10 分死亡预测评分在非静脉曲张性胃肠道出血的独立人群中得到了成功验证。PNED 评分准确且优于 Rockall 评分。需要在国际层面进行进一步的外部验证。